Source

Balanced, disclaimer-heavy memo (repeatedly: "not a recommendation… speculative… complete loss of capital") — not a pump. It self-discloses the headline risks (huge NAV premium, high fees, Level-3 valuation uncertainty, SPV/SAFE opacity, dilution facility). The thesis: BOT is a public-market wrapper for a concentrated private/pre-IPO humanoid + embodied-AI basket.

Snapshot (as of doc's 2026-05-16)

Portfolio holdings (as of 2026-02-28)